Pneumococcal Conjugate Vaccine for stem cell transplant recipients 2022-2024 (2024-2025, 2025-2026)
Ministry of Social Affairs and Health · Uusimaa
Perustiedot
- Tarjousten määräaika
- ma 31.1.2022 klo 12.00 (päättynyt)
- Hankkija
- Ministry of Social Affairs and Health, Y-tunnus 0244685-8
- Toteutuspaikka
- Uusimaa (FI1B1)
- Hankintalaji
- Tavarahankinta
- Menettely
- EU-hankinta
- Ilmoituksen tyyppi
- Hankintailmoitus
- Arvioitu kokonaisarvo
- Ei ilmoitettu
- Pääasiallinen CPV
- 33651600 Rokotteet
- Julkaistu
- 11.12.2021
Ilmoituksen teksti
Alkuperäinen teksti Hilmasta, muuttamattomanaThe Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request your tender for Pneumococcal conjugate Vaccine for stem cell transplant recipients belonging to the National Vaccination Programme in Finland.
The contract period is about two years 2022-2024. The procurement contains two options to extend the contract for the periods 2024-2025 and 2025-2026.
Estimated quantity for the contract period including option is 5000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%.
The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Please note that all times given in the Call for tender refer to local time in Finland.
Tender annexes:
Annex 1 Contract
Annex 2 JYSE 2014 Supplies (Updated April 2017)
Annex 3 Handi
Erän kuvaus
The purpose of STM and the Customer is to procure Pneumococcal conjugate Vaccine for stem cell transplant recipients required for the National Vaccination Programme in Finland. The tendered vaccine must be suitable for both children and adults.
More information about National Vaccination Programme and vaccinations can be found on the website of the National Institute for Health and Welfare:
https://thl.fi/en/web/infectious-diseases-and-vaccinations/vaccines-a-to-z/pneumococcal-vaccines/pneumococcal-conjugate-vaccine-pcv
The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority".
The subject of procurement and the mandatory requirements relating to it are described in detail in this Call for Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders.
CONTRACT PERIOD
The duration of the contract is about two years. Estimated quantity for the contract period is 2500 doses. The customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%.
The Contract period shall enter into force once the contract has been signed, and expire when all contractual duties have been performed. After the contract period, the Customer reserves the right for the option described in section "Description of renewals".
Tenders will be compared in the manner described in section "Grounds for decision" of the Call for Tender.
Lisätiedot
Tenderers may ask clarification questions using the Supplier Portal. The questions must be in English and will be answered in English. To guarantee the equal treatment of tenderers, questions posed in any other way cannot be answered.
Please note that all times given in the Call for tender refer to local time in Finland.
Please note that the online connection to the Supplier Portal is periodically slow and the download time will take time. Please fill out the tenders information in good time before the deadline expires.
Lisätiedot
This procurement is detailed in the contract notice published on TED (Tenders Electronic Daily) online version and on the Hilma electronic procurement portal at www.hankintailmoitukset.fi as well as this Call for Tender and its Annexes.
Hankinnan vaiheet
-
Hankintailmoitustämä ilmoitus
Tarjouspyyntö julkaistiin, määräaika 31.1.2022 klo 12.00.
-
Voittaja: Pfizer Oy.